# Ernexa Therapeutics Inc.: Form S-1, filed Nov 18, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1
- Filed: 2021-11-18
- Accepted by EDGAR: Nov 18, 2021, 17:11 ET
- Period: not reported
- Accession: 0001140361-21-038586
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121038586/ny20001244x1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121038586/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121038586/ny20001244x1_s1.htm

Filed Nov 18, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-038586. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
